止血药的临床应用分析

Analysis on Clinical Application of Hemostatics

目的:了解止血药的应用特点与趋势。方法:对我院2015年住院患者应用止血药的销售金额、用药频度(DDDs)、日均费用(DDC)及金额排序/DDDs排序(A/B)值等进行回顾性分析。结果:我院蛇毒血凝酶销售金额位居首位;DDDs排序列前3位的是酚磺乙胺、蛇毒血凝酶、维生素K1,抗纤溶药中氨甲环酸DDDs位居首位,酚磺乙胺A/B值高而DDC值低。结论:我院住院患者应用止血药以促凝血功能药为主,尤其是血凝酶类药物。医院应加强外科围手术期止血药临床合理使用。

Objective： Tolearnthe characteristics and trends of the application of hemostatics in our hospital. Methods： A retrospective analysis was made on data of hemostatics sales amount,DDDs,DDC,order of sales amount / order of DDDs（ A / B） of hospitalized patients application of hemostatics in 2014. Results： The sales amount of hemocoagulase ranks highest. The top three are etamsylate,hemocoagulase,vitamin K1 in DDDs sequence. Tranexamic acid ranks the order of DDDs of anti-plasmin. Etamsylate has a high value of A /B but a low DDC. Conclusion： Inpatients of our hospital are mainly treated with hemostatics medicine with effect of procoagulant such as hemocoagulase in particular. It should strengthen the clinical rational use of hemostatics in the perioperative period of surgery.